Tema ETFs’s Madrigal Pharmaceuticals MDGL Stock Holding History

Tema ETFs’s Portfolio MDGL Stock Details MDGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$750K	Sell	1,489 -10	-0.7%	-$5.28K	0.03%	347
2026 Q2	$805K	Sell	1,499 -52	-3%	-$26.6K	0.03%	332
2026 Q1	$812K	Sell	1,551 -20	-1%	-$9.6K	0.05%	276
2025 Q4	$915K	Sell	1,571 -50	-3%	-$25.5K	0.07%	254
2025 Q3	$743K	Sell	1,621 -180	-10%	-$67.2K	0.06%	306
2025 Q2	$545K	Sell	1,801 -477	-21%	-$142K	0.14%	133
2025 Q1	$755K	Sell	2,278 -1,342	-37%	-$441K	0.23%	100
2024 Q4	$1.12M	Buy	+3,620	New	+$1.02M	0.46%	59

Other funds holding MDGL

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Bourgeon Capital Management Darien, Connecticut $696M AUM 39.92% 1-Year Est. Return

Shikiar Asset Management New York $398M AUM 33.64% 1-Year Est. Return

Stanley-Laman Group Berwyn, Pennsylvania $915M AUM 50.26% 1-Year Est. Return

Hennion & Walsh Asset Management Parsippany, New Jersey $3.42B AUM 25.82% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

Newbridge Financial Services Group Boca Raton, Florida $868M AUM 42.47% 1-Year Est. Return

SGH

Sivik Global Healthcare Greenwich, Connecticut $175M AUM 28.78% 1-Year Est. Return

Quadrant Capital Group Cincinnati, Ohio $3.7B AUM 33.76% 1-Year Est. Return

Gateway Investment Advisers Cincinnati, Ohio $11B AUM 34.31% 1-Year Est. Return

Tema ETFs's MDGL Position: Q3 2026 in Review

Tema ETFs reduced its Madrigal Pharmaceuticals (MDGL) stake by 0.67% in Q3 2026, selling an estimated $5.28K and leaving 1,489 shares worth $750K. The position accounts for 0.03% of the portfolio, ranked #347.

Tema ETFs first reported a position in MDGL in Q4 2024 and has held it in 8 quarters since. The position peaked at $1.12M in Q4 2024. 46 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

Tema ETFs held 1,489 shares of Madrigal Pharmaceuticals worth $750K as of Q3 2026.
Tema ETFs sold 10 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $5.28K.
Madrigal Pharmaceuticals made up 0.03% of Tema ETFs's portfolio in Q3 2026, its #347 holding.
Tema ETFs first reported a position in Madrigal Pharmaceuticals in Q4 2024 and has held it in 8 quarters since.
Tema ETFs's Madrigal Pharmaceuticals position peaked at $1.12M in Q4 2024.
46 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.